Nifuratel-containing initial anti-Helicobacter pylori triple therapy in children

Helicobacter

Volumn 12, Issue 2, 2007, Pages 132-135

  Nijevitch, Alexander A ^a,c   Sataev, Valery U ^c   Akhmadeyeva, Elsa N ^a   Arsamastsev, Alexander G ^a,b  

^a Children's Republican Hospital Ufa   (Russian Federation)

^b BASHKIR STATE MEDICAL UNIVERSITY   (Russian Federation)

^c NONE

Author keywords

Amoxicillin; Bismuth; Children; Gastritis; Helicobacter pylori; Nifuratel

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; NIFURATEL;

ADOLESCENT; ANOREXIA; ARTICLE; CHILD; CHRONIC GASTRITIS; CONFIDENCE INTERVAL; DARK STOOL; DYSPEPSIA; EVALUATION; FATIGUE; FEMALE; GASTROINTESTINAL ENDOSCOPY; GIEMSA STAIN; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELENA; NAUSEA; OUTPATIENT; PEDIATRICS; PRIORITY JOURNAL; RASH; SIDE EFFECT; TONGUE BLACKENING; TONGUE DISEASE; URINE; URINE DISCOLORATION; VOMITING;

ADOLESCENT; AMOXICILLIN; CHILD; DRUG THERAPY, COMBINATION; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; NIFURATEL; ORGANOMETALLIC COMPOUNDS; PEPTIC ULCER; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

HELICOBACTER PYLORI;

EID: 33847040978     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2007.00482.x     Document Type: Article

References (33)

1. Chelimsky G, Dahms BB, Czinn S. In: Lifschitz CH, ed. Pediatric Gastroenterology and Nutrition in Clinical Practice. New York: Marcel Dekker, 2002:501-15.
2. Gold BD, Colletti RB, Abbott M, et al. Medical position statement: the North American Society for Pediatric Gastroenterology and Nutrition. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr 2000;31:490-7.
3. De Giacomo C, Fiocca R, Villani L, et al. Helicobacter pylori infection and chronic gastritis: clinical, serological and histologic correlations in children treated with amoxicillin and colloidal bismuth subcitrate. J Pediatr Gastroenterol Nutr 1990;11:310-6.
4. Nijevitch AA, Farztdinov KM, Sataev VU, et al. Helicobacter pylori infection in childhood: results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole. J Gastroenterol Hepatol 2000;15:1243-50.
5. Jones NL, Sherman P, Fallone CA, et al. Canadian Helicobacter Study Group Consensus Conference: update on the approach to Helicobacter pylori infection in children and adolescents - an evidence-based evaluation. Can J Gastroenterol 2005;19:399-408.
6. Vandenplas Y, Blecker U. Helicobacter pylori infection in children. Acta Paediatr 1998;87:1105-12.
7. McLoughlin RM, O'Morain CA, O'Connor HJ. Eradication of Helicobacter pylori: recent advances in treatment. Fundament Clin Pharmacol 2005;19:421-7.
8. Gschwantler M, Dragosics B, Schütze K, et al. Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori - a randomized, controlled trial. Aliment Pharmacol Ther 1999;13:1063-9.
9. Gisbert JP, Gonzáles L, Calvet X, et al. Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther 2000;14:1319-28.
10. Nakayama Y, Graham DY. Helicobacter pylori infection: diagnosis and treatment. Expert Rev Anti-Infect Ther 2004;2:599-610.
11. Miyaji H, Azuma T, Ito S, et al. Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxicillin in vitro and in clinical treatment in Japan. Aliment Pharmacol Ther 1997;11:1131-6.
12. Gosciniak GM, Iwanczak B, Przondo-Mordarska A, Grabinska J, Iwanczak F. Increase in resistance to metronidazole and clarithromycin to Helicobacter pylori strains isolated from children before and after treatment in the time span of 1997-2001. Gut 2002;51 (Suppl. 11):A89.
13. Koudryavtseva L, Isakov VA, Ivanikov IO, Zaitseva SV. Evolution of H. pylori primary resistance to antimicrobial agents in Moscow (Russia) in 1996-98. Gut 2000;47 (Suppl. 1):A8.
14. Walsh D, Goggin N, Rowland M, Durnin M, Moriarty S, Drumm B. One-week treatment for Helicobacter pylori infection. Arch Dis Child 1997;76:352-5.
15. Israel DM, Hassall E. Treatment and long-term follow-up of Helicobacter pylori-associated duodenal ulcer disease in children. J Pediatr 1993;123:53-8.
16. Segura AM, Gutiérrez O, Otero W, Angel A, Genta RM, Graham DY. Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1997;11:529-32.
17. Fakheri H, Merat S, Hosseini V, Malekzadeh R. Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication. Aliment Pharmacol Ther 2004;19:89-93.
18. Liu W-Z, Xiao S-D, Shi Y, et al. Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1999;13:317-22.
19. Nijevitch AA, Shcherbakov PL, Sataev VU, Khasanov RSh, Al-Khashash R, Tuygunov MM. Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy with nifuratel to furazolidone. Aliment Pharmacol Ther 2005;22:881-7.
20. Krivtsova LA, Kononov AV, Tepljakov AA, Vas'kina TV, Novikova LD. [The use of macmiror in the scheme of eradication therapy of Helicobacter- associated gastritis in children.] Pediatrija 2001;5:60-2. (In Russian).
21. Mendling W, Mailland F. Microbiological and pharmacotoxicological profile of nifuratel and its favourable risk/benefit ratio for the treatment of vulvo-vaginal infections. A Rev Arzneimittelforschung 2002;52:8-13.
22. Mitchell HM, Bohane TD, Tobias V, et al. Helicobacter pylori infection in children: potential clues to pathogenesis. J Pediatr Gastroenterol Nutr 1993;16:120-5.
23. Oderda G. Management of Helicobacter pylori infection in children. Gut 1998;43 (Suppl. 1):S10-3.
24. Nijevitch AA, Sataev VU, Al-Khashash R. Is fibronectin (Fn) a factor for optimal quality of healing of peptic ulcer (PU), associated with Helicobacter pylori? Helicobacter 2003;8:434.
25. Oderda G, Marinello D, Lerro P, et al. Eradication of Helicobacter pylori is useful for symptom resolution in children with gastritis. Gut 2002;51(Suppl. 11):A87.
26. Oderda G, Marinello D, Lerro P, et al. Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multi-center trial. Helicobacter 2004;9:293-302.
27. Elitsur Y, Ruessmann H, Lawrence Z, Koletzko S. Clarithromycin resistance in Helicobacter pylori-infected children - the West Virginia experience. Helicobacter 2003;8:459.
28. Kalach N, Benhamou P, Dupont C, et al. Helicobacter pylori in children: acquisition of antimicrobial resistance after an initial course of treatment. J Clin Microbiol 2001;39:3018-9.
29. Shcherbakov PL, Vartapetova E, Nijevitch A, Salmova V, Teljashev E, Chamidullin F. Safety of bismuth therapy in Helicobacter pylori-positive children. Helicobacter 2003;8:455.
30. Wong WM, Wong BCY, Lu H, et al. One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies. Aliment Pharmacol Ther 2002;16:793-8.
31. Nijevitch AA, Khasanov RS, Sataev VU. Ranitidine bismuth citrate plus amoxicillin and furazolidone in the eradication of H. pylori in children. Gut 2001;49 (Suppl. 11):A77.
32. Haas CE, Nix DE, Schentag JJ. In vitro selection of resistant Helicobacter pylori. Antimicrob Agents Chemother 1990;34:1637-41.
33. Schütze K, Hentschel E, Hirschl A. Clarithromycin or amoxycillin plus high-dose ranitidine in the treatment of Helicobacter pylori - positive functional dyspepsia. Eur J Gastroenterol Hepatol 1996;8:41-6.